During Pregnancy: Buprenorphine or Buprenorphine Plus Naloxone?
In this large observational study, similar and, in some instances, more favorable neonatal and maternal outcomes were observed in pregnancies exposed to buprenorphine combined with naloxone compared to pregnancies exposed to buprenorphine alone.
Bridging the Gap: Addressing Ethnic and Racial Inequities in Perinatal Depression Treatment
This study provides valuable insight into the inequities in perinatal mental healthcare and suggests that the most significant barriers to mental healthcare may occur at the provider referral level.
Is it Safe for Breastfeeding Mothers to Use Benzodiazepines?
Clinically significant anxiety symptoms are common during the postpartum period and frequently complicate the treatment of postpartum depression.  While SSRIs are indicted for the treatment anxiety symptoms, especially when they co-occur with depression, many women may need to use a benzodiazepine for managing more severe symptoms of anxiety or insomnia.Â
Recruiting for Research Study: THRIVE (Targeting Health and Resilience for Individuals with a Vulnerable Eating History)
Do you have a history of an eating disorder or eating problems and are currently in your first or second trimester of pregnancy?
Your Patient Has Postpartum Depression: Do You Use Zuranolone or a Traditional Antidepressant?
A study using indirect comparisons suggests that zuranolone is more effective than the SSRIs for the treatment of PPD. Should it be the first choice for treatment?
Risk of Malformations in Children with Prenatal Exposure to Antidepressants and Benzodiazepines
This large cohort study from Taiwan indicates that the concomitant use of antidepressants and benzodiazepines during the first trimester is not associated with a substantial increase in risk for overall malformations.